The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Urological research

• Publication date

  2003-07-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00240-003-0324-3PMID 12879322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.

  2000cited by this paper
• Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.

  2000cited by this paper
• Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry.

  1998cited by this paper
• The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

  1998cited by this paper
• Molecular alterations in bladder cancer

  1998cited by this paper
• Expression of bcl-2 and bcl-X in bladder cancer.

  1998cited by this paper
• Expression of bcl-2 protein in gastric carcinoma and its significance.

  1998cited by this paper
• bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.

  1998cited by this paper
• Expression of bcl‐6 protein in normal skin and epidermal neoplasms

  1997cited by this paper
• Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis.

  1997cited by this paper
• Expression of the apoptosis suppressing bcl‐2 protein in transitional cell bladder tumours

  1996cited by this paper
• Transcriptional repression by the proto-oncogene BCL-6.

  1996cited by this paper
• Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.

  1996cited by this paper
• The BCL6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage.

  1996cited by this paper
• BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.

  1995cited by this paper
• Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.

  1995cited by this paper
• BCL-6 protein is expressed in germinal-center B cells.

  1995cited by this paper
• Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.

  1994cited by this paper
• Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

  1993cited by this paper
• Maturation of the immune response in germinal centers.

  1991cited by this paper
• Intraclonal generation of antibody mutants in germinal centres

  1991cited by this paper

• B-cell lymphoma 6 in breast cancer: molecular mechanisms and clinical significance

  2025cites this paper
• Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3.

  2020cites this paper
• Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma

  2020cites this paper
• Androgen Receptor Predicts First and Multiple Recurrences in Non-Muscle Invasive Urothelial Carcinoma of the Bladder

  2018cites this paper
• Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma

  2016cites this paper
• Immunostaining of Bcl-2 and HER2/neu in urinary bladder carcinoma

  2016cites this paper
• Urinary Bladder and Urachus

  2015cites this paper
• FOXO responses to Porphyromonas gingivalis in epithelial cells

  2015cites this paper
• Cancer-Related Genetic Profile of Precancerous Lesions and the Normal Urothelium in UCC Patients

  2014cites this paper
• An immunohistochemical study on BCL-6 expression in odontogenic cysts

  2014influential citation
• BCL6 overexpression is associated with decreased p19ARF expression and confers an independent prognosticator in gallbladder carcinoma

  2014cites this paper
• Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.

  2014cites this paper
• Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters

  2012cites this paper
• The role of Rac1-modulated gene transcription in tumorigenesis

  2012cites this paper
• Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways.

  2011cites this paper
• Molecular markers and bladder carcinoma: Schistosomal and non-schistosomal.

  2011cites this paper
• u rinary Bladder

  2011cites this paper
• Urothelial Cancer Stem Cells

  2010cites this paper
• Cancer stem cells in urologic cancers.

  2010cites this paper
• Rac1 Signaling Modulates BCL-6-Mediated Repression of Gene Transcription

  2009cites this paper
• Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of P53 and Bcl-2

  2009cites this paper
• Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder is Associated with Down-Regulated CPP32 Expression and BCL-2 Positivity

  2009cites this paper
• Efficacy of recombinant adenovirus‐mediated double suicide gene therapy in human keloid fibroblasts

  2008cites this paper
• Current Status and Issues in Cancer Stem Cell Study

  2008cites this paper
• BCL-6 prevents mammary epithelial apoptosis and promotes cell survival.

  2008cites this paper
• Bladder Cancer Initiating Cells (BCICs) Are Among EMA−CD44v6+ Subset: Novel Methods for Isolating Undetermined Cancer Stem (Initiating) Cells

  2008cites this paper
• Expression of STAT3 and Bcl-6 oncoprotein in sodium arsenite-treated SV-40 immortalized human uroepithelial cells.

  2007cites this paper
• BCL-2, TP53 and BAX protein expression in superficial urothelial bladder carcinoma.

  2007cites this paper
• BCL6 Gene Mutations in Transitional Cell Carcinomas

  2007cites this paper
• Expression of p 63 , bcl-2 , bcl-6 and p 16 in Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin

  2005cites this paper